AmpliPhi Biosciences is a biotech company engaged in the development of anti-bacterial solutions to enhance human health through the application of its proprietary bacteriophage platform. Its lead product development programs target gram negative bacterial infections that are resistant to antibiotic treatments. They include BioPhage-PA for the treatment of chronic inner ear infections and BioPhage-PR for the treatment of lung infections in cystic fibrosis patients. For further information, visit the company’s Web site at www.targen.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: